𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Effects of gender and menopausal status — 24-month results

✍ Scribed by H. Dobnig; M.R. Warner; B.L. Langdahl; R. Möricke; K. See; F. Marin

Book ID
116321631
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
52 KB
Volume
44
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of teriparatide versus alendrona
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six–month results of a randomized, double-blind, controlled trial
✍ Kenneth G. Saag; Jose R. Zanchetta; Jean-Pierre Devogelaer; Robert A. Adler; Ric 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective To compare the bone anabolic drug teriparatide (20 μg/day) with the antiresorptive drug alendronate (10 mg/day) for treating glucocorticoid‐induced osteoporosis (OP). ## Methods This was a 36‐month, randomized, double‐blind, controlled trial in 428 subjects with OP (ages